Overview Financials News + Filings Key Docs Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Asset disposition
|
Monterey Innovation Acquisition Corp
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/13/2023 |
8-K
| Quarterly results |
08/15/2023 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
07/10/2023 |
8-K
| Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submiss... |
06/30/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
06/30/2023 |
8-K
| Other Events Interactive Data |
06/30/2023 |
8-K
| Other Events Interactive Data |
06/16/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
06/02/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
05/18/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
05/15/2023 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
03/31/2023 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
03/10/2023 |
8-K
| Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
Docs:
|
"CERTIFICATE OF AMENDMENT OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF MONTEREY BIO ACQUISITION CORPORATION",
"Agreement”), dated March 9, 2023, is entered into by and between [●] and [●] . Whereas, Transferor currently holds [●] shares of common stock, par value $0.0001 per share , of Monterey Bio Acquisition Corporation , and",
"Letter Agreement”), is being delivered to you in accordance with the Share Transfer Agreement, dated March 9, 2023, by and between Chardan Monterey Investments LLC , a Delaware limited liability company, and NorthStar Bio Ventures LLC (the “NorthStar Co-Sponsor",
"Chardan Co-Sponsor”), a Delaware limited liability company and NorthStar Bio Ventures LLC , a Delaware limited liability company and Monterey Bio Acquisition Corporation (the “Company",
"ASSIGNMENT AND ASSUMPTION OF ADMINISTRATIVE SERVICES AGREEMENT Reference is hereby made to that certain Administrative Service Agreement, dated September 30, 2021 , by and between Monterey Bio Acquisition Corporation and NorthStar Bio Ventures, LLC , pursuant to which Provider makes available to the Company certain office space, utilities, general and administrative services and secretarial support as may be reasonably required by the Company in exchange for a sum of $10,000 per month. This Assignment and Assumption of Administrative Services Agreement , between Provider , Chardan Monterey Investments LLC and, solely for purposes of providing the consent to this Assignment required by the Agreement, the Company. For good and valuable consideration, the receipt and sufficiency of which is h...",
"Monterey Innovation Acquisition Corp." |
|
02/14/2023 |
SC 13G/A
| MMCAP International Inc. SPC reports a 9.7% stake in Monterey Bio Acquisition Corp. |
02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
10/11/2022 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs:
|
"PROMISSORY NOTE   Principal Amount:  $525,000 Dated as of October 7, 2022   Monterey Bio Acquisition Corporation, a Delaware corporation , promises to pay to the order of NorthStar Bio Ventures, LLC, a Delaware limited liability company, or its registered assigns or successors in interest , or order, the principal sum of Five Hundred Twenty Five Thousand Dollars , or such lesser amount as shall have been advanced by Payee to Maker and shall remain unpaid under this Note, in lawful money of the United States of America, on the terms and conditions described below.  All payments on this Note shall be made by check or wire transfer of immediately available funds or as otherwise determined by the Maker to such account as the Payee may from time to time...",
"PROMISSORY NOTE   Principal Amount:  $175,000 Dated as of October 7, 2022   Monterey Bio Acquisition Corporation, a Delaware corporation , promises to pay to the order of Chardan Monterey Investments LLC, a Delaware limited liability company, or its registered assigns or successors in interest , or order, the principal sum of One Hundred Seventy Five Thousand Dollars , or such lesser amount as shall have been advanced by Payee to Maker and shall remain unpaid under this Note, in lawful money of the United States of America, on the terms and conditions described below.  All payments on this Note shall be made by check or wire transfer of immediately available funds or as otherwise determined by the Maker to such account as the Payee may ..." |
|
09/30/2022 |
8-K
| Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submiss...
Docs:
|
"CERTIFICATE OF AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF MONTEREY BIO ACQUISITION CORPORATION",
"AMENDMENT TO INVESTMENT MANAGEMENT TRUST AGREEMENT THIS AMENDMENT TO THE INVESTMENT MANAGEMENT TRUST AGREEMENT is made as of September 29, 2022, by and between Monterey Bio Acquisition Corporation, a Delaware corporation , and Continental Stock Transfer & Trust Company, a New York corporation . Capitalized terms contained in this Amendment, but not specifically defined in this Amendment, shall have the meanings ascribed to such terms in that certain Investment Management Trust Agreement, dated September 30, 2021, by and between the parties hereto . WHEREAS, a total of $116,150,000 was placed in the Trust Account from the IPO and sale of private warrants; WHEREAS, Section 1 of the Trust Agreement provides that the Trustee is to liquidate the Trust Account and distribute the Property in the ..." |
|
09/08/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
08/24/2022 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
08/11/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
05/13/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
03/29/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
02/14/2022 |
SC 13G
| Karpus Management, Inc. reports a |
02/14/2022 |
SC 13G
| NORTHSTAR BIO VENTURES, LLC reports a 13.5% stake in Monterey Bio Acquisition Corporation |
02/14/2022 |
SC 13G/A
| Saba Capital Management, L.P. reports a 6.4% stake in Monterey Bio Acquisition Corporation |
02/07/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/02/2022 |
SC 13G/A
| Space Summit Capital LLC reports a 0% stake in Monterey Bio Acquisition Corporation Units |
12/03/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
12/01/2021 |
SC 13G/A
| Feis Lawrence reports a 1.5% stake in Monterey Bio Acquisition Corporation |
11/17/2021 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
11/12/2021 |
10-Q
| Quarterly Report for the period ended September 30, 2021 |
10/12/2021 |
8-K
| Quarterly results |
10/08/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
10/07/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
|
|
|